Paraneoplastic Syndrome Presenting Combined Central and Peripheral Demyelination Associated with Anti-CV2/CRMP5 and Anti-NF186 Antibodies: A Case Report
Abstract
:1. Introduction
2. Case Report
3. Discussion
4. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Kamm, C.; Zettl, U.K. Autoimmune disorders affecting both the central and peripheral nervous system. Autoimmun. Rev. 2012, 11, 196–202. [Google Scholar] [CrossRef]
- Darnell, R.B.; Posner, J.B. Paraneoplastic syndromes involving the nervous system. N. Engl. J. Med. 2003, 349, 1543–1554. [Google Scholar] [CrossRef] [PubMed]
- Campetella, L.; Papi, C.; Sabatelli, E.; Marini, S.; Iorio, R. Real-world application of the updated diagnostic criteria for paraneoplastic neurological syndromes. J. Neuroimmunol. 2022, 372, 577972. [Google Scholar] [CrossRef] [PubMed]
- Xie, C.; Wang, Z.; Zhao, N.; Zhu, D.; Zhou, X.; Ding, J.; Wu, Y.; Yu, H.; Guan, Y. From PNS to CNS: Characteristics of anti-neurofascin 186 neuropathy in 16 cases. Neurol. Sci. 2021, 42, 4673–4681. [Google Scholar] [CrossRef] [PubMed]
- Vallat, J.-M.; Mathis, S.; Magy, L.; Bounolleau, P.; Skarzynski, M.; Heitzmann, A.; Manso, C.; Devaux, J.; Uncini, A. Subacute nodopathy with conduction blocks and anti-neurofascin 140/186 antibodies: An ultrastructural study. Brain 2018, 141, e56. [Google Scholar] [CrossRef] [Green Version]
- Burnor, E.; Yang, L.; Zhou, H.; Patterson, K.R.; Quinn, C.; Reilly, M.M.; Rossor, A.; Scherer, S.S.; Lancaster, E. Neurofascin antibodies in autoimmune, genetic, and idiopathic neuropathies. Neurology 2017, 90, e31–e38. [Google Scholar] [CrossRef]
- Delmont, E.; Manso, C.; Querol, L.; Cortese, A.; Berardinelli, A.; Lozza, A.; Belghazi, M.; Malissart, P.; Labauge, P.; Taieb, G.; et al. Autoantibodies to nodal isoforms of neurofascin in chronic inflammatory demyelinating polyneuropathy. Brain 2017, 140, 1851–1858. [Google Scholar] [CrossRef] [Green Version]
- Sundaram, S.; Nair, S.S.; Jaganmohan, D.; Unnikrishnan, G.; Nair, M. Relapsing lumbosacral myeloradiculitis: An unusual presentation of MOG antibody disease. Mult. Scler. J. 2020, 26, 509–511. [Google Scholar] [CrossRef] [PubMed]
- Wang, Y.-Q.; Chen, H.; Zhuang, W.-P.; Li, H.-L. The clinical features of combined central and peripheral demyelination in Chinese patients. J. Neuroimmunol. 2018, 317, 32–36. [Google Scholar] [CrossRef]
- Kawamura, N.; Yamasaki, R.; Yonekawa, T.; Matsushita, T.; Kusunoki, S.; Nagayama, S.; Fukuda, Y.; Ogata, H.; Matsuse, D.; Murai, H.; et al. Anti-neurofascin antibody in patients with combined central and peripheral demyelination. Neurology 2013, 81, 714–722. [Google Scholar] [CrossRef]
- Ogata, H.; Matsuse, D.; Yamasaki, R.; Kawamura, N.; Matsushita, T.; Yonekawa, T.; Hirotani, M.; Murai, H.; Kira, J.-I. A nationwide survey of combined central and peripheral demyelination in Japan. J. Neurol. Neurosurg. Psychiatry 2016, 87, 29–36. [Google Scholar] [CrossRef] [PubMed]
- Antoine, J.C.; Honnorat, J.; Camdessanché, J.P.; Magistris, M.; Absi, L.; Mosnier, J.F.; Petiot, P.P.; Kopp, N.; Michel, D. Paraneoplastic anti-cv2 antibodies react with peripheral nerve and are associated with a mixed axonal and demyelinating peripheral neuropathy. Ann. Neurol. 2001, 49, 214–221. [Google Scholar] [CrossRef] [PubMed]
- Siles, A.M.; Martínez-Hernández, E.; Araque, J.; Diaz-Manera, J.; Rojas-García, R.; Gallardo, E.; Illa, I.; Graus, F.; Querol, L. Antibodies against cell adhesion molecules and neural structures in paraneoplastic neuropathies. Ann. Clin. Transl. Neurol. 2018, 5, 559–569. [Google Scholar] [CrossRef] [Green Version]
- Shah, S.; Campo, R.V.D.; Kumar, N.; McKeon, A.; Flanagan, E.P.; Klein, C.; Pittock, S.J.; Dubey, D. Paraneoplastic myeloneuropathies. Neurology 2021, 96, e632–e639. [Google Scholar] [CrossRef]
- Dubey, D.; Lennon, V.A.; Gadoth, A.; Pittock, S.J.; Flanagan, E.P.; Schmeling, J.E.; McKeon, A.; Klein, C.J. Autoimmune CRMP5 neuropathy phenotype and outcome defined from 105 cases. Neurology 2018, 90, e103–e110. [Google Scholar] [CrossRef]
- Thaxton, C.; Pillai, A.M.; Pribisko, A.L.; Dupree, J.L.; Bhat, M.A. Nodes of Ranvier act as barriers to restrict invasion of flanking Paranodal domains in myelinated axons. Neuron 2011, 69, 244–257. [Google Scholar] [CrossRef] [Green Version]
- Feinberg, K.; Eshed-Eisenbach, Y.; Frechter, S.; Amor, V.; Salomon, D.; Sabanay, H.; Dupree, J.L.; Grumet, M.; Brophy, P.J.; Shrager, P.; et al. A glial signal consisting of gliomedin and NrCAM clusters axonal Na+ channels during the formation of nodes of ranvier. Neuron 2010, 65, 490–502. [Google Scholar] [CrossRef] [Green Version]
- Devaux, J.J.; Miura, Y.; Fukami, Y.; Inoue, T.; Manso, C.; Belghazi, M.; Sekiguchi, K.; Kokubun, N.; Ichikawa, H.; Wong, A.H.Y.; et al. Neurofascin-155 IgG4 in chronic inflammatory demyelinating polyneuropathy. Neurology 2016, 86, 800–807. [Google Scholar] [CrossRef] [Green Version]
- Querol, L.; Nogales-Gadea, G.; Rojas-Garcia, R.; Diaz-Manera, J.; Pardo, J.; Ortega-Moreno, A.; Sedano, M.J.; Gallardo, E.; Berciano, J.; Blesa, R.; et al. Neurofascin IgG4 antibodies in CIDP associate with disabling tremor and poor response to IVIg. Neurology 2014, 82, 879–886. [Google Scholar] [CrossRef] [Green Version]
- Fehmi, J.; Davies, A.J.; Walters, J.; Lavin, T.; Keh, R.; Rossor, A.M.; Munteanu, T.; Delanty, N.; Roberts, R.; Bäumer, D.; et al. IgG1 pan-neurofascin antibodies identify a severe yet treatable neuropathy with a high mortality. J. Neurol. Neurosurg. Psychiatry 2021, 92, 1089–1095. [Google Scholar] [CrossRef] [PubMed]
- Stengel, H.; Vural, A.; Brunder, A.-M.; Heinius, A.; Appeltshauser, L.; Fiebig, B.; Giese, F.; Dresel, C.; Papagianni, A.; Birklein, F.; et al. Anti–pan-neurofascin IgG3 as a marker of fulminant autoimmune neuropathy. Neurol. Neuroimmunol. Neuroinflamm. 2019, 6, e603. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Appeltshauser, L.; Junghof, H.; Messinger, J.; Linke, J.; Haarmann, A.; Ayzenberg, I.; Baka, P.; Dorst, J.; Fisse, A.L.; Grüter, T.; et al. Anti-pan-neurofascin antibodies induce subclass-related complement activation and nodo-paranodal damage. Brain, 2022; online ahead of print. [Google Scholar] [CrossRef] [PubMed]
- Bien, C.G.; Schänzer, A.; Dargvainiene, J.; Dogan-Onugoren, M.; Woermann, F.; Strickler, A. Co-occurrence of antibodies against dipeptidyl-peptidase-like protein-6 and aquaporin-4 during a case of paraneoplastic encephalitis. Clin. Neurol. Neurosurg. 2020, 197, 106093. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Liu, B.; Zhou, L.; Zheng, Y.; Sun, C.; Lin, J. Paraneoplastic Syndrome Presenting Combined Central and Peripheral Demyelination Associated with Anti-CV2/CRMP5 and Anti-NF186 Antibodies: A Case Report. Brain Sci. 2023, 13, 374. https://doi.org/10.3390/brainsci13030374
Liu B, Zhou L, Zheng Y, Sun C, Lin J. Paraneoplastic Syndrome Presenting Combined Central and Peripheral Demyelination Associated with Anti-CV2/CRMP5 and Anti-NF186 Antibodies: A Case Report. Brain Sciences. 2023; 13(3):374. https://doi.org/10.3390/brainsci13030374
Chicago/Turabian StyleLiu, Bingyou, Lei Zhou, Yongsheng Zheng, Chong Sun, and Jie Lin. 2023. "Paraneoplastic Syndrome Presenting Combined Central and Peripheral Demyelination Associated with Anti-CV2/CRMP5 and Anti-NF186 Antibodies: A Case Report" Brain Sciences 13, no. 3: 374. https://doi.org/10.3390/brainsci13030374
APA StyleLiu, B., Zhou, L., Zheng, Y., Sun, C., & Lin, J. (2023). Paraneoplastic Syndrome Presenting Combined Central and Peripheral Demyelination Associated with Anti-CV2/CRMP5 and Anti-NF186 Antibodies: A Case Report. Brain Sciences, 13(3), 374. https://doi.org/10.3390/brainsci13030374